• Je něco špatně v tomto záznamu ?

Possible hepatocellular toxicity of EGCG under the influence of an inflammagen

Ibrahim G. Saleh, Zulfiqar Ali, Naohito Abe, Farid M. Hamada, Mohamed F. Abd-Ellah, Larry A. Walker, Ikhlas A. Khan, Mohammad K. Ashfaq

. 2014 ; 12 (4) : 291-299.

Jazyk angličtina Země Česko

Typ dokumentu práce podpořená grantem, hodnotící studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc15018305

Epigallocatechin-3-gallate (EGCG) is widely used as a weight controlling supplement. Concerns about its safety evoked after cases of hepatotoxicity occurred upon its use. The underlying factors that could be involved in EGCG associated hepatotoxicity are not fully studied. In this study, we investigated the possible impact of lipopolysaccharide (LPS), as an inflammagen, on the effect of EGCG on hepatocytes. HepG2 cells were treated with different concentrations of EGCG (100, 200, 500 μM), with and without LPS (10 nM)-presensitization of the cells. Viability of HepG2 cells decreased with the increased concentrations of EGCG; the viability was even lesser in LPS-presensitized cells. Oxidative stress (Ox.LDL and CXCL16), the expression of nuclear retinoic receptors (RAR, RXR) and the biomarkers of hepatocellular injury (TNFα, TGFβ1) were all relatively higher in LPS-presensitized cells compared to non-sensitized cells upon treatment with EGCG. Sensitization of HepG2 cells with LPS alone did not affect the viability or any of the other biomarkers considered in this study. In conclusion, EGCG alone can be harmful to liver at high concentrations and this effect may become more pronounced under the influence of an inflammagen.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc15018305
003      
CZ-PrNML
005      
20151012175048.0
007      
ta
008      
150525s2014 xr ad f 000 0|eng||
009      
AR
024    7_
$2 doi $a 10.1016/j.jab.2014.03.001
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Saleh, Ibrahim G. $u National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA; Department of Pharmacology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt
245    10
$a Possible hepatocellular toxicity of EGCG under the influence of an inflammagen / $c Ibrahim G. Saleh, Zulfiqar Ali, Naohito Abe, Farid M. Hamada, Mohamed F. Abd-Ellah, Larry A. Walker, Ikhlas A. Khan, Mohammad K. Ashfaq
504    __
$a Literatura
520    9_
$a Epigallocatechin-3-gallate (EGCG) is widely used as a weight controlling supplement. Concerns about its safety evoked after cases of hepatotoxicity occurred upon its use. The underlying factors that could be involved in EGCG associated hepatotoxicity are not fully studied. In this study, we investigated the possible impact of lipopolysaccharide (LPS), as an inflammagen, on the effect of EGCG on hepatocytes. HepG2 cells were treated with different concentrations of EGCG (100, 200, 500 μM), with and without LPS (10 nM)-presensitization of the cells. Viability of HepG2 cells decreased with the increased concentrations of EGCG; the viability was even lesser in LPS-presensitized cells. Oxidative stress (Ox.LDL and CXCL16), the expression of nuclear retinoic receptors (RAR, RXR) and the biomarkers of hepatocellular injury (TNFα, TGFβ1) were all relatively higher in LPS-presensitized cells compared to non-sensitized cells upon treatment with EGCG. Sensitization of HepG2 cells with LPS alone did not affect the viability or any of the other biomarkers considered in this study. In conclusion, EGCG alone can be harmful to liver at high concentrations and this effect may become more pronounced under the influence of an inflammagen.
650    12
$a katechin $x analogy a deriváty $x farmakologie $x toxicita $7 D002392
650    _2
$a polyfenoly $x farmakologie $x toxicita $7 D059808
650    _2
$a techniky in vitro $x metody $x statistika a číselné údaje $7 D066298
650    _2
$a buňky Hep G2 $x chemie $x imunologie $x účinky léků $7 D056945
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    12
$a hepatocyty $x chemie $x imunologie $x účinky léků $7 D022781
650    12
$a zánět $7 D007249
653    00
$a epigallocatechin-3-gallate (EGCG)
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a hodnotící studie $7 D023362
700    1_
$a Ali, Zulfiqar $u National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA $7 gn_A_00004200
700    1_
$a Abe, Naohito $u National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA $7 gn_A_00000494
700    1_
$a Hamada, Farid M. $u Department of Pharmacology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt
700    1_
$a Abd-Ellah, Mohamed F. $u Department of Pharmacology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt $7 gn_A_00000335
700    1_
$a Walker, Larry A. $u National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA; Department of Pharmacology, School of Pharmacy, University of Mississippi, University, MS 38677, USA; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11557, Saudi Arabia
700    1_
$a Khan, Ikhlas A. $u National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA; Department of Pharmacognosy, School of Pharmacy, University of Mississippi, University, MS 38677, USA
700    1_
$a Ashfaq, Mohammad K. $u National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA $7 gn_A_00009286
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 12, č. 4 (2014), s. 291-299 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2014/04/14.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y 4 $z 0
990    __
$a 20150522215938 $b ABA008
991    __
$a 20151012175237 $b ABA008
999    __
$a ok $b bmc $g 1078538 $s 901236
BAS    __
$a 3
BMC    __
$a 2014 $b 12 $c 4 $d 291-299 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK121 $d 20151012 $a NLK 2015-26/dk

Najít záznam

Citační ukazatele

Možnosti archivace